We are excited to share new research from our group! A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation. @CellReports
https://t.co/jHsRp9CLO1
Our study on CD4+ T cell epitopes of SARS-CoV-2 is published online in @CellReports. We define model antigens presented by HLA-DR1 and assess the impact of Spike mutations on T cell recognition 1/8. @GallimoreGodkin@CUSystemsImmu https://t.co/8LwBhst9qQ
Extremely excited to start today as a recipient of a Health and Care Research Wales - Health Research Fellowship! Many thanks to the support of @ResearchWales in helping to ask questions about how the immune system recognises cancer.
We are proud to announce the recipients of our 2021-22 funding call awards.
Read more about the people and projects we invested in:
https://t.co/Ae7ubPMdUB
A tribute to Dr. Ling Felce.
I just read about the horrific Oxford accident: a cyclist trapped beneath a lorry and died at the scene. The very same place I hated and dreaded. Then, I found out that the person who died, was my former labmate and friend Ling! I'm shocked and 1/7
Very pleased to share our study, first author @PiroozZareie, with @RossjohnLab@GrasLab, showing that canonical TCR-pMHC docking is critical for localization of coreceptor-associated Lck to the CD3 complex for signaling @ScienceMagazine@MonashBDI https://t.co/CepHGw7rAt
In collaboration with Andrew Brooks' lab and Julian Vivian's lab, latest paper on Natural Killer cell receptor (KIR3DL1) recognition of HLA-I.
https://t.co/Mok2SIghwn @ImagingCoE @TheDohertyInst@MonashBDI
Here's a new review, co-written by me and Prof Andy Sewell, on MR1-restricted T-cells in different disease states, published in Current Opinion in Immunology. Link to the free paper (for 50 days) here! https://t.co/UfEswEG1D2